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A B S T R A C T
The plant metallothionein 2 protein from Cicer arietinum (cicMT2) is a typical member of the plant MT subfamily
p2 that is characterized by an N- and C-terminal cysteine- (Cys-)rich, metal binding sequence connected by a
long cysteine-free linker region. cicMT2 coordinates up to five ZnII or CdII ions by its 14 cysteine thiolate groups
forming a single metal-thiolate cluster. While MTs from other phyla are considerably well-studied, many details
about plant MTs are missing. In this study the metallation pathway of cicMT2 is investigated using mass
spectrometry. To evaluate the influence of the linker region as well as the interplay of the two Cys-rich stretches,
the full-length cicMT2 protein as well as the individual Cys-rich domains with and without the linker region
were analysed. Up to three CdII ions can be coordinated by the eight Cys residues of the N-terminal part and up to
two CdII ions by the six Cys residues of the C-terminal sequence. However, no preferential binding to either of the
two sequences is observed, which is in-line with the closely similar apparent binding constants of the individual
domains obtained from competition reactions with the chelator 1,2-bis(2-amino-5-fluorophenoxy)ethane-
N,N,N′,N′-tetraacetic acid. The combination of limited proteolytic digestion, mass spectrometry, dynamic light
scattering, size-exclusion chromatography, and 19F NMR spectroscopy enables us to draw conclusions about the
overall protein-fold and the cluster formation process.
Significance
Metallothioneins are ubiquitously found in many organisms and
play a pivotal role in metal ion homeostasis and detoxification. In
particular, submetallated species are considered crucial for effective
function, but received little attention so far as they are largely un-
structured and tedious to handle. Here, we show that the metallation of
a plant metallothionein is non-cooperative, ensuring that upon sub-
metallation only low amounts of unstructured apo-species that are
prone to proteolytic degradation exist. Results also reveal that the en-
igmatic linker region of plant metallothioneins only plays a subordinate
role in metal-thiolate cluster formation as clusters will also form be-
tween the separate, non-linked domains.
1. Introduction
Plant growth, development, as well as survival depend on a multi-
tude of internal and external factors [1,2]. The storage, transport, and
homeostasis of essential metal ions such as ZnII and CuI, as well as the
detoxification of toxic metal ions such as CdII, HgII, PbII, or AgI is car-
ried out, among others, by metallothioneins (MTs), a superfamily of
small (< 10 kDa) cytosolic, cysteine-rich, and metal ion coordinating
proteins [3–8]. MTs preferentially bind d10 metal ions, which are then
arranged in thermodynamically stable metal-thiolate clusters [9]. The
extraordinary high Cys content and the fact that the thiolate groups
reside in the reduced state within these cluster structures suggest an
additional protective function against reactive oxygen species (ROS),
resulting in the formation of disulfide bridges and consequently metal
ion release [10–13]. As MTs are generally devoid of secondary struc-
tural elements they are largely unstructured and highly flexible in the
metal-free (apo) or submetallated state. Generally, only fully metallated
species achieve a three-dimensional fold, that might - or not - impose
sufficient rigidity to allow for structural investigations by NMR spec-
troscopy or X-ray crystallography.
Cicer arietinum (chickpea) metallothionein 2 (cicMT2) belongs to the
plant MT subfamily p2. The main characteristic of this as well as of the
p1 and p3 subfamilies of plant MTs, is the presence of N- and C-terminal
Cys-rich sequences that are separated by a rather long Cys-free linker
region. Predictions reveal that these regions contain secondary struc-
tural elements (mainly β-sheets) that were further analysed experi-
mentally for cork oak MT2 and chickpea MT1 using CD, IR, and Raman
spectroscopy [14,15]. The N-terminal region of cicMT2 contains eight
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and the C-terminal region six cysteine residues as characteristic for all
plant MT2 proteins, and the separating linker region has a length of 41
amino acids. Together, all Cys residues can coordinate up to five di-
valent metal ions in vitro leading to the formation of a single metal-
thiolate cluster with a hairpin-like arrangement of the protein backbone
[16].
The aim of this work is to study the metallation pathway of cicMT2
with CdII ions, which has never been performed for any plant MT so far.
Studies of the metallation pathway are of special interest as recent
findings indicate that generally MTs occur sub-metallated in vivo [17].
Ideally, such a study should identify the individual binding sites for
each metal ion equivalent added to the protein during the folding
process. While NMR spectroscopy using a specific labelling scheme
could be a viable method for this purpose [18], it is not applicable for
the plant MT1, MT2, and MT3 forms studied so far: Firstly, due to the
general low abundance of secondary structural elements the fold of MTs
is highly dependent on metal ion coordination. Hence sub-metallated
species as occurring during a (non-cooperative) metallation process can
be expected to be largely unstructured and thus highly flexible, re-
sulting in peak broadening or even complete disappearance of signals.
Secondly, as already the fully-metallated, and hence the presumably
most structured, species of the mentioned plant MT forms did not yield
any meaningful NMR spectra so far, tackling the metallation process
with NMR is unfortunately completely unrealistic.
Accordingly, for the metallation studies described herein we are
restricted to the identification of the respective Cys-rich region (N- or C-
terminal), to which binding of each subsequently added metal ion
equivalent occurs. We showed previously, that limited proteolytic di-
gestion of Cd5cicMT2 with Tritirachium album proteinase K leads to
cleavage of the linker region at multiple sites but not within the Cys-
rich regions, and that the assembly consisting of the single metal-
thiolate cluster and the N- and C-terminal Cys-rich regions remains
intact during size exclusion chromatography [16]. Subsequent analysis
of the cleaved construct with MALDI-TOF spectrometry led to the dis-
sociation of the cluster and only the metal-free peptide fragments were
detected, due to the experimental conditions used (pH, ionization vol-
tage) [16,19]. Hence for the present study the more gentle method of
electrospray ionization mass spectrometry (ESI-MS) will be used for the
study of the cleavage products, which can be applied at and above
physiological pH to preserve the CdII-thiolate bonds. The potential of
ESI-MS to determine metal ion-to-protein stoichiometries of MTs has
been shown in several studies [20–22]. In particular, also the co-
operative and non-cooperative binding of ZnII, CdII, and AsIII to the
human MT_1a isoform as well as the stepwise metallation of the isolated
β- and α-domains were successfully analysed [23–26]. Using a combi-
nation of N-ethylmaleimide labeling and tandem mass spectrometry
experiments the removal of CdII from human MT_2A was investigated
[27,28].
The general strategy followed here will thus be the stepwise addi-
tion of CdII ions to full-length cicMT2 followed by limited proteolytic
digestion and analysis of the fragments with ESI-MS to identify metal
ion binding to the respective Cys-rich regions. For comparison, also
metal ion coordination to the individual Cys-rich regions will be in-
vestigated using the separately prepared peptides and hence avoiding
the additional digestion step. To reduce the number of protease clea-
vage sites (that are located in the linker) and also to investigate a po-
tential influence of the linker region on the metal ion binding pre-
ferences of the Cys-rich regions, another cicMT2 construct was
produced that contains an artificial tobacco etch virus (TEV) protease
cleavage site roughly in the center of the linker region. Results obtained
with this construct will be compared to the respective separately pre-
pared longer N- and C-terminal peptides (see Fig. 1). Identification of
the binding region for each metal ion is complemented and corrobo-
rated by informations obtained from size exclusion chromatography,
dynamic light scattering (DLS), and 19F NMR spectroscopy.
2. Experimental procedures
2.1. Chemicals and solutions
The enzymes and purification systems used for plasmid construction
were purchased from Promega AG (Dübendorf, Switzerland), and
Sigma-Aldrich (Buchs, Switzerland). All buffers and chemicals were
ACS grade or comparable from Sigma-Aldrich (Buchs, Switzerland),
Biosolve (Sarl, France), Fisher Bioreagents (Reinach, Switzerland), and
Chemie Brunschwig (Basel, Switzerland). Plasmid pRK793 for the
production of TEV protease in Escherichia coli was a gift from David
Waugh (Addgene plasmid # 8827) [29]. Rabbit liver MT2 from Enzo
Life Sciences AG (Lausen, Switzerland) was a gift from Milan Vašák. All
solutions were prepared using Millipore water and were degassed under
vacuum. If necessary, solutions were saturated with argon.
2.2. Description of constructs
Full-length cicMT2 was obtained from the previously generated
vector pGtMT2 [30]. The construct encoding the N-TEV-C_cicMT2
protein (see Fig. 1) was designed by introducing a TEV protease re-
cognition site (ENLYFQ) into the linker region before residue Ser45. For
the study of the separate N- and C- terminal domains two different sets
of peptides were designed. The first set is based on the N-TEV-C_cicMT2
construct with the N-terminal peptide comprising residues Ser1-Ala44
(denoted N1) and the C-terminal peptide residues Ser45-Lys78 (C1).
The second set represents the shorter peptides that are obtained ex-
perimentally after cleavage of full-length cicMT2 with proteinase K, i.e.
residues Ser1-Asp27 (N2) and Glu60-Lys78 (C2), as described pre-
viously (Fig. 1) [16]. All coding sequences were cloned into the pGEX-
4T-1 vector (GE Healthcare, Uppsala, Sweden) using the BamHI and
XmaI restriction sites, which results in expression of proteins with a
thrombin-cleavable N-terminal glutathione S-transferase (GST) tag.
However, as we aim to generate proteins that carry their native N-
terminal amino acid, an additional TEV protease cleavage site was in-
troduced between the thrombin cleavage site and the respective coding
protein sequence for all constructs used. The only exception is the N-
TEV-C_cicMT2 construct, which already possesses a TEV cleavage site in
the linker region (see above), and therefore here only the vector derived
thrombin cleavage site was included in the sequence of the fusion
protein. For the complete vector sequences see the Suppl. Mat.
Fig. 1. Amino acid sequences of constructs. Cys residues are highlighted in black, the TEV cleavage site in construct N-TEV-C_cicMT2 is underlined and marked in
gray. See text for details.
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2.3. Protein/peptide expression and purification
All constructs were recombinantly expressed in the E. coli strain
BL21. Cells from a glycerol stock stored at −80 °C were grown at 37 °C
overnight in lysogeny broth (LB) medium containing 100 μg/mL am-
picillin (LBamp+). Overnight precultures were diluted 1:100 into LBamp
+ and incubated at 37 °C until an OD600 of 0.8. Expression was induced
with 1 mM isopropyl-β-D-thiogalactoside and cells were grown for
6–8 h at 30 °C. Cells were harvested by centrifugation and stored at
−80 °C for further use.
Cell pellets were resuspended in 1× phosphate-buffered saline
(PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM NaCl, 2.7 mM KCl,
pH 7.3), lysed by ultrasonication and centrifuged. The respective su-
pernatant was filtered through a 45 μm polyethersulfone filter (Sarstedt
AG, Sevelen, Switzerland) and applied to a GST affinity column
(GSTPrep FF 16/10, GE Healthcare). The column was first washed with
50 mL 1× PBS buffer containing 10 mM ethylenediaminetetraacetic
acid (EDTA) (pH 8), and then with 100 mL 1× PBS buffer. Fusion
peptides were stripped from the column using 5 mL of 50 mM Tris-HCl
pH 8 supplemented with 50 mM reduced glutathione (GSH), and frac-
tions were collected based on UV absorption at 280 nm. GSH was re-
moved by overnight dialysis against 2 L of 50 mM Tris-HCl buffer with a
pH of 8 for constructs cicMT2 and N-TEV-C_cicMT2 and 9 for N1, N2,
C1, and C2, depending on the respective isoelectric point (pI). All
constructs except N-TEV-C_cicMT2 were cleaved with 1 mg TEV pro-
tease (in 25 mM Na2HPO4·H2O, 100 mM NaCl, 10% glycerol, and 2 mM
dithiothreitol, pH 7.5) per 40 mg of fusion protein overnight at room
temperature followed by removal of the GST tag and TEV protease by
size exclusion chromatography (SEC) using a HiLoad 16/60 Superdex
75 pg column (GE Healthcare) for cicMT2 or the respective 30 pg
column for the N- and C-terminal peptides in 10 mM ammonium
acetate, pH 7.4 or 9, again depending on the pI value. The N-TEV-
C_cicMT2 fusion protein was cleaved with 1 unit thrombin per mg of
protein in 50 mM Tris-HCl pH 8, for 20 h at room temperature and the
GST tag was removed by SEC (HiLoad 16/60 Superdex 75 pg column)
in 10 mM ammonium acetate pH 7.4. Eluted fractions of all protein and
peptide constructs were lyophilized.
2.4. Preparation of apo-protein forms
The metal-free or apo-forms of N-TEV-C_cicMT2 as well as of the
peptide fragments were prepared by dissolving the respective lyophi-
lized protein in a buffer containing 10 mM Tris-HCl, pH 7.5 (pH 6.8 for
the N2 and C2 peptides), 50 mM NaCl, 25 mM Tris(2-carboxyethyl)
phosphine hydrochloride (TCEP) and 20 mM EDTA. For the preparation
of apo-cicMT2 50 mM Tris-HCl, pH 8, and 10 mM CaCl2 as required for
subsequent cleavage with proteinase K was used. All proteins were
purified by SEC using a Superdex Peptide 10/300 GL column (GE
Healthcare) and the different buffers as indicated above depending on
the protein/peptide. All solutions were vacuum degassed and argon
saturated, and all steps were performed under strictly anaerobic con-
ditions. For ESI-MS analyses, samples were desalted using C18 Zip Tips
(Millipore, Billerica, MA, USA) and 0.1% formic acid in 50% acetoni-
trile at pH 2–3 for elution.
2.5. CdII-binding capacity of the terminal peptides
All titrations were performed inside an anaerobic chamber equipped
with a palladium catalyst and filled with a 5% hydrogen/95% nitrogen
gas mix (Coy Lab, Michigan, USA). The freshly prepared apo-peptides
were titrated with incremental amounts of CdCl2 (0–4 eq.) using se-
parate solutions for each titration step. In addition, 1:1 mixtures of N1/
C1 and N2/C2 were mixed with 0–6 eq. of CdII ions. After each metal
ion addition a UV/Vis spectrum in the range of 200–600 nm was
recorded on a Cary 60 scan spectrophotometer (Agilent Technologies
AG, Basel, Switzerland) using a scan speed of 600 nm/min.
Additionally, each of the four terminal peptides was oversaturated with
CdII ions (5–6 eq.), passed through the SEC Superdex Peptide 10/300
GL column to remove unbound metal ions, and analysed by ESI-MS to
confirm the maximum CdII binding capacity of the respective peptide.
2.6. CdII metallation pathway analysis
The apo-forms of the two full-length proteins, of the four separate
terminal peptides as well as of the 1:1 mixtures of N1/C1 and N2/C2
were incubated with 0–5 eq. of CdII ions in the presence of 5 mM TCEP
(pH 7). In addition, each N-TEV-C_cicMT2 sample was incubated with
TEV protease (1 mg TEV protease: 20 mg protein), that was prepared as
described before [31] with some modifications [32] in 10 mM Tris-HCl
pH 8, and 50 mM NaCl buffer overnight at room temperature and each
cicMT2 sample was digested with proteinase K using a molar ratio of
5:2 for 2 h at 28 °C in 50 mM Tris-HCl pH 8 and 10 mM CaCl2. After
metal ion addition, all samples were applied to the Superdex Peptide
10/300 GL column using 10 mM Tris-HCl, pH 7.5 or 6.8 for N2 and C2,
and 50 mM NaCl as running buffer. Digested samples were desalted
using C18 Zip Tips and 10 mM NH4Ac in 50% MeOH, pH 7.5 for elu-
tion. Subsequent analysis was performed by ESI-MS at pH 7 to evaluate
CdII-binding to the respective Cys-rich regions and fragments.
2.7. DLS of cicMT2
Small aliquots of cicMT2 loaded with different equivalents of CdII
ions were taken prior to digestion with proteinase K, centrifuged for
10 min, and analysed by DLS (DynaPro Titan, Wyatt Technology). In
addition, a sample of Cd5N-TEV-C_cicMT2 was investigated. Each DLS
analysis was performed with 20 μL of a 100 μM protein solution at room
temperature, using 10 acquisitions with 5–10 s acquisition time each,
and a laser power between 20 and 100%. The average hydrodynamic
radius of each sample was obtained by curve fitting with the provided
Dynamics software.
2.8. Determination of CdII binding constants by 19F NMR
19F NMR spectra were recorded on a Bruker AV2-400 MHz spec-
trometer with a 90 MHz spectral width, a 0.73 s acquisition time, and a
2 s pulse repetition rate. The respective protein and peptide con-
centrations in all samples were adjusted to result in CdII ion con-
centrations in the 130–350 μM range. As competitive chelator, 2.5 mM
1,2-bis(2-amino-5-fluorophenoxy)ethane-N,N,N′,N′-tetraacetic acid
(5F-BAPTA) was used in 10 mM Tris-HCl, pH 6.8 or 7.5, and the ionic
strength was 50 mM at 25 °C. To ensure that the equilibrium was
reached, measurements were performed after 15 h incubation time.
Binding constants were calculated according to Hasler et al. [33]. Exact
metal ion concentrations in the samples were measured by flame atomic
absorption spectroscopy. For the calculation, initial value for the CdII-
5F-BAPTA binding constant of log KCd(BAPTA) 11.75 [34] was adjusted
to 50 mM ionic strength with the Chelator program [35] resulting in
binding constant of log KCd(BAPTA) 11.73 or 5.37·10
11 M−1. Rabbit liver
Cd7MT2 was used as a control. Apparent binding constants were de-
termined after 30 min, 1 h, 2 h, 4 h, 8 h, and 12 h incubation under the
same conditions.
2.9. ESI-MS and MALDI mass spectrometry
All samples were analysed on a Synapt G2 quadrupole time-of-flight
spectrometer (Waters, UK). Electrospray parameters were capillary
2.7 V, cone 50 V, and source temperature 80 °C. MS scans were accu-
mulated and further processed with the software MassLynx 4.1 (Waters,
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UK). Due to some limitations of the MaxEnt Software for complex
mixtures of peptides with various masses, no deconvolution was per-
formed for the experiment with proteinase K cleaved cicMT2. In this
case, the quantitative analysis was performed based on the intensities of
the doubly charged ions.
Cd5cicMT2 cleaved with proteinase K and purified over SEC was
analysed with matrix assisted laser desorption/ionization mass spec-
trometry (MALDI-MS). For MALDI-MS, the samples were desalted using
C18 ZipTips (Millipore, Billerica, MA, USA) and spotted onto the MALDI
target (MTP 384 target polished steel TF, Bruker Daltonics, Bremen,
Germany) with 2 μL of α-Cyano-4-hydroxycinnamic acid (α-CHCA)
solution in acetonitrile/water/trifluoroacetic acid (50:50:0.1) for sub-
sequent MALDI-TOF measurements. The concentration of α-CHCA was
5 mg/mL.
MALDI measurements were performed on an ultrafleXtreme MALDI-
TOF/TOF mass spectrometer equipped with a smartbeam laser (Bruker
Daltonics). The measurement parameters were programmed in
flexControl (Version 3.4): laser frequency of 1000 Hz in the positive
reflector mode with acquisition ranging from 700 to 5000 Da. Final
spectra consisted of 1000–3000 shots per analysis. MS and MS/MS data
of ions of interest were acquired manually. The mass spectrometer was
calibrated in MS mode for every new set of samples; in the MS/MS
mode, the precursor ion was used as the reference mass in the in-
dividual analysis. Detected peptides were identified using high energy
fragmentation technique. In this investigation, MS/MS data were ac-
quired using MALDI LIFT TOF/TOF mass spectrometry in the positive
ion mode. The fragmentation was induced by the smartbeam laser
without use of collision gas. Precursor ions were then accelerated and
selected in timed ion gate. In the LIFT cell, the fragment ions were
further accelerated and the MS/MS data recorded. The assignment of
the peptides and their fragments to the protein sequence was performed
using the BioTools software (Bruker Daltonics).
3. Results and discussion
3.1. Binding capacity of the terminal peptides
3.1.1. Metal ion titrations monitored with UV spectroscopy
The apo-forms of the four terminal peptides were titrated with in-
creasing amounts of CdII ions, and the increase of the S → CdII ligand-
to-metal charge transfer (LMCT) band at 250 nm was monitored with
UV spectroscopy (Fig. 2). The maximum absorptivity of peptides N1
and N2 is reached after addition of three CdII ions. For the C-terminal
peptides C1 and C2 the maximum is reached when two CdII ions are
added.
In all titrations, a red-shift of the LMCT bands can be observed that
is indicative for the formation of a cluster structure [36–38], and hence
the transition of some of the initially terminal thiolate ligands, that are
mostly contributing to the absorptivity at 250 nm, into ligands that
bridge two metal ions. Those bridging thiolate ligands give rise to the
red-shifted LMCT bands in the roughly 260–270 nm range. The red-shift
upon cluster formation can be accentuated by plotting the ratio ε250nm/
ε265nm against the number of Cd
II equivalents added, and the transition
point is approximately the maximum/intersection of the first two linear
fits per plot (Fig. 3) [39]. For both terminal peptides N1 and N2, this
intersection is observed when 1.5 equivalents of CdII are added, and for
the second equiv. the absorptivity increase at 265 nm gains in im-
portance (Fig. 3A). Considering that the N-terminal domain features
eight Cys residues that could in theory accommodate two separate
tetrahedral CdCys4 sites, this indication for an early onset of cluster
formation is surprising. The further analysis of this finding would re-
quire additional (structural) investigations. Both C-terminal peptides
behave like expected. The maximum is reached with the addition of one
equiv. of CdII. Further addition of metal ions to this six Cys residues
containing domain would require cluster formation, which is indeed
evident from the decreasing ε250nm/ε265nm ratio (Fig. 3B).
3.1.2. Mass spectrometry
ESI-MS spectra confirm the maximum CdII binding capacity for the
two N-terminal peptides (Cd3N1, Mr(obs) 4689.33 Da, Mr(calc)
4692.16 Da; Cd3N2, Mr(obs) 2858.96 Da, Mr(calc) 2861.21 Da) as well
as for C2 (Cd2C2, Mr(obs) 2203.43 Da, Mr(calc) 2205.04 Da), while also
showing some submetallated species (Fig. 4). For peptide C1, however,
next to the signal of the Cd2-species (Cd2C1, Mr(obs) 3701.61 Da, Mr
(calc) 3703.67 Da), also an intensive signal for a Cd3 species (Cd3C1, Mr
(obs) 3813.0 Da, Mr(calc) 3816.08 Da) is observed and in addition,
signals that indicate dimer-formation with four (Cd4(C1)2, Mr(obs)
7399.2 Da, Mr(calc) 7407.35 Da) and five Cd
II ions (Cd5(C1)2, Mr(obs)
7512.2 Da, Mr(calc) 7519.75 Da) are detected. Although this dimer-
isation of the separate C-terminal domain is probably not physiologi-
cally relevant, it is interesting from a coordination chemistry point of
view. Considering the ratio of five CdII ions to just 12 Cys ligands, it is
clear that some sort of cluster structure must be present that is con-
necting the two peptides, and that the number of bridging thiolate
groups in this arrangement must be quite high. An inorganic model
compound with five HgII ligands and 12 coordinating thiolate groups, in
which each HgII ion shows a tetrahedral tetrathiolate environment is
known from the literature [40], but any such compound would be
unprecedented for MTs or other biological systems. Hence, a structural
model is difficult to propose, especially considering the smaller ionic
radius of CdII compared to HgII, being unfavourable for a highly bridged
structure.
Why is the higher coordination number not evident from the in-
crease of the LMCT band in the UV spectra?
On the one hand, only small changes are expected, considering (i) 2
CdII ions per C1 peptide for a Cd2C1 species versus 2.5 Cd
II per C1 in the
Cd5(C1)2 dimer and (ii) that for coordination of additional Cd
II ions
terminal thiolates are transformed into bridging thiolates, which have a
relatively small effect on the LMCT band. On the other hand, a highly
bridged, well-ordered cluster structure should lead to a bathochromic
shift of the LMCT bands as particularly observed for the N-terminal, but
less for the C-terminal peptides. Accordingly, it can be also hypothe-
sized that, due to steric reasons, there is either not a pure Cd-thiolate
cluster and other ligands, e.g. carboxylates of Glu and Asp, complete the
CdII coordination spheres, or that some of the coordination sites are
vacant or in fast exchange (share ligands) as recently shown for a
bacterial MT from Pseudomonas fluorescens [32]. The highly metallated
Cd3C1 species can be explained as an artificial adduct species generated
when the Cd5(C1)2 falls apart under ESI-MS conditions. It is unlikely
that such a species could be specifically prepared by CdII addition to the
C1 peptide.
Titration of the peptide mixtures with CdII ions shows incremental
increase of the LMCT band at 250 nm up to five CdII ions for N2/C2,
while the 1:1 mixture of N1 and C1 coordinates only four CdII ions by
thiolate groups (Fig. 2). Apparent is again a red-shift of the LMCT bands
in the N2/C2 mixture indicative for a bridged cluster structure. Again,
rather early onset of cluster formation is observed based on the max-
imum value for the ε250nm/ε265nm ratio at already two equiv. of Cd
II,
indicating one isolated CdCys4 site each in the N-terminal and the C-
terminal peptide, respectively, and cluster formation thereafter
(Fig. 3C).
3.2. Metallation pathway of cicMT2
3.2.1. Proteinase K cleavage of cicMT2
First, fully metallated cicMT2 (Cd5cicMT2) was cleaved with T.
album proteinase K and the cleavage products were analysed by MALDI-
MS (Suppl. Material). In contrast to the previous study [16] only a 2.5-
fold excess of protease was used. Detected peptides were subsequently
sequenced with MALDI-MS/MS, and the fragment ions were aligned
with the entire protein sequence as well as with the most likely frag-
ments using the Bruker BioTools 3.2 software. In agreement with the
previous results, selective cleavage resulting in N2 and C2 as well as in
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two slightly shorter peptides (N2-short (1-23) and C2-short (61-78))
was observed.
The ESI-MS spectrum of proteinase K cleaved apo-cicMT2 at acidic
conditions (pH 2) shows all N- and C-terminal peptides in the +2
charged state, i.e. observed m/z values are 1009.31 (N2-short), 1262.38
(N2), 925.82 (C2-short), and 990.34 (C2) (Fig. 5A). It should be noted,
that the intensities of the N-terminal peptides are lower than the in-
tensities of the C-terminal peptides in all spectra due to a better ioni-
zation of the latter in the ESI-MS experiments. Hence the signal in-
tensity cannot be correlated to the respective peptide concentration in
the sample. Subsequently, apo-cicMT2 was titrated with 1–5 equiv. CdII
and ESI-MS spectra were recorded at physiological pH (Fig. 5B–F) as
well as at pH 2 in order to differentiate CdII-bound peptides from non-
coordinating linker fragments (data not shown). Based on the +2
charge states of the observed peptide fragments a mass increase by
56 Da relative to the apo-peptide fragment is indicative for the chela-
tion of one CdII ion. However, as the background noise of the spectra in
Fig. 5 is rather high due to side-products from unspecific cleavage and
the presence of smaller fragments from the linker region, assignment of
the different N-terminal species is not always unambiguous and
Fig. 2. UV spectra of the apo-protein form titrations with CdII ions (A and C), and plots of extinction values at 250 nm and 265 nm (B and D) for the indicated
peptides as well as of the respective 1:1 mixtures.
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quantification of the smaller peaks is highly error prone. In addition,
the masses of one of the linker fragments (YTEQTTSETL; Mr(calc)
1172.21 Da) and of Cd3N2-short (Mr(calc) 1177.31 Da) are too close
together to be resolved in separate peaks making quantification even
more difficult. Hence, the metallation process of the N-terminal frag-
ment can be monitored only qualitatively. Cleavage of Cd1cicMT2
reveals roughly equally intense signals for the Cd1- and Cd2-forms of the
N-terminal peptide fragments, while the intensity of the signals for the
Cd1-forms of the C-terminal peptide fragments is slightly higher than
that for the Cd2-forms (Fig. 5B). Only low amounts of apo-species are
detected. The ESI-MS spectrum after cleavage of Cd2cicMT2 is very
similar and in addition, formation of a Cd3N2 species can be observed
Fig. 3. Plots of the quotient of extinction values at 250 nm and 265 nm against the CdII equivalents added for A) N1 and N2, B) C1 and C2, as well as C) 1:1 mixtures
of N1/C1 and N2/C2. Linear least-square fits for the respective areas are included to better visualize the trends.
Fig. 4. Non-deconvoluted ESI-MS spectra of the four terminal peptides: A) Cd3N1 (Mr(obs) 4689.33 Da, Mr(calc) 4692.16 Da), B) Cd2C1 Mr(obs) 3701.61 Da, Mr(calc)
3703.67 Da), C) Cd3N2 (Mr(obs) 2858.96 Da, Mr(calc) 2961.21 Da), and D) Cd2C2 (Mr(obs) 2203.43 Da, Mr(calc) 2205.04 Da).
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(Fig. 5C). However, assignment of the Cd3N2-short species is not un-
ambiguously as discussed and hence a reliable quantification is not
possible. A major change occurs for the Cd3cicMT2 sample, as for the
first time C-terminal Cd3 species are observed, while the highest in-
tensity is detected for the C-terminal Cd2 species followed by the Cd1
species (Fig. 5D). Again, formation of a Cd3 species by the C-terminal
peptides cannot be explained with the enigmatic Cd-thiolate clusters of
MTs and further interpretations are highly hypothetic. An alternative
view is the presence of an additional metal ion binding site not invol-
ving any thiolate ligands. An indication for the feasibility of this as-
sumption is the observation of a Cd6cicMT2 species reported earlier
[41]. Also at this titration point, signals in-line with possible N-terminal
Cd3 species are observed, although quantification is again difficult due
to the high signal-to-noise ratio in the respective region of the ESI-MS
spectrum and the mentioned general low intensity of the signals of the
N-terminal peptides. In the Cd4cicMT2 and Cd5cicMT2 samples as-
signment of N-terminal Cd3 species is now unambiguous, because in
contrast to the spectra after addition of 1–3 equiv. of CdII, no linker
signal is detected in the spectra at pH 2. Disappearance of this signal is
probably related to the altered fold of cicMT2 at higher metal ion load
and accordingly to a different cleavage pattern. In contrast, the in-
tensities of the C-terminal Cd3 species are diminished. Most sig-
nificantly, signals for peptide fragments that are joined by a metal-
thiolate cluster are observed for the first time, that is for Cd5(N2-short
+C2-short) and Cd5(N2-short+C2) (Fig. 5E, F). The reason why no
clustering involving the N2 peptide is observed, might be again the
general low intensity of that peptide in ESI-MS. The relative abundance
of the C-terminal Cd2 species remains high in both samples, suggesting
that these species are relatively stable and favored by the C-terminal
peptides.
3.2.2. 1:1 mixtures of N2 and C2
How important for the metallation pathway is the fact, that the N-
and C-terminal Cys-rich regions are linked to each other? Does this
influence the CdII binding preference to a specific domain? Is hetero-
dimeric cluster formation still observed? To answer these questions, the
same metallation experiment as performed for the full-length protein
was also conducted with the separate Cys-rich domains, using the se-
quences for the peptides obtained after limited proteolytic digestion
with proteinase K, i.e. N2 and C2. N2 and C2 are nearly devoid of re-
sidues originating from the linker region. The peptides were prepared
separately, mixed in a 1:1 molar ratio, loaded with CdII ions, and passed
through a Superdex Peptide 10/300 GL column for buffer exchange
before ESI-MS analysis (Fig. 6). Compared to the digestion experiment
with proteinase K described above, it is now possible to deconvolute the
spectra and a considerable lower noise and less background signals are
seen. This allows now also the analysis of the N-terminal species with
higher reliability.
Spectra measured at acidic conditions show signals of both peptides
with observed mass values of 1980.4 Da for C2, and 2524.49 Da for N2
(Fig. 6, + 0 CdII). The detected species in the spectra after addition of
one and two CdII ions are very similar to those seen in the experiment
with proteinase K cleavage (Fig. 5B, C). In both spectra, Cd1 species of
both peptides are observed as well as Cd2 species of the N-terminal
domain. Cd2 species of the C-terminal domain only appear after addi-
tion of two equivalents of CdII. While after addition of the first CdII
equivalent the Cd1 species dominate for both Cys-rich regions and
hence no binding preference to either domain is evident, the Cd1:Cd2
species ratio roughly inverses for N2, but not C2, when the second CdII
ion is added. This indicates the preferential formation of Cd2N2 over
Cd2C2 and hence a higher stability of the second metal ion binding sites
Fig. 5. Non-deconvoluted ESI-MS spectra of proteinase K cleaved cicMT2 samples upon stepwise metallation with 0–5 CdII ions. The numbers correspond to the
equivalents of CdII bound to the respective peptide fragment. The color of the respective numbers corresponds to the color used for the labeling of the apo peptide
forms.
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in N2 compared to C2. As for full-length cicMT2, addition of three CdII
ions shows the formation of an N-terminal Cd3 species, but no Cd3C2
species is detected (Fig. 6). For C2 the Cd1 species has still the highest
intensity. Hence binding of the third metal ion to N2 seems to be fa-
vored over C2. From this titration point on, signals for a Cd4N2C2 (Mr
(obs) 4945.87 Da, Mr(calc) 4954.74 Da) and Cd5N2C2 cluster (Mr(obs)
5055.47 Da, Mr(calc) 5067.15 Da) can be detected. This shows clearly
that cluster formation neither depends on the linker region nor does it
require a covalent link between the two Cys-rich regions. Upon addition
of five CdII ions also homo-dimers of the form Cd4(C2)2 (Mr(obs)
4401.16 Da, Mr(calc) 4410.08 Da) and Cd5(C2)2 (Mr(obs) 4512.00 Da,
Mr(calc) 4522.49 Da) appear, which are clearly not physiologically
relevant. In this spectrum also a Cd3C2 species is observed for the first
time, which again might indicate a third binding site in this peptide or
represents an artifact when the Cd5 cluster falls apart during ionization
as discussed above. In addition, a low intensity signal for a Cd6N2C2
species is detected (Fig. 6). Overall and in particular, the coordination
of three CdII ions to the N-terminus clearly shows that shortening of the
linker region does not reduce the binding capacity for divalent metal
ions. A similar observation was reported for Quercus suber (cork oak)
MT2 [14].
3.2.3. TEV cleavage of N-TEV-C_cicMT2
To increase cleavage specificity and to minimize the amount of
fragments that were observed after proteinase K cleavage, a TEV pro-
tease recognition site (ENLYFQ) was introduced into the linker region
of cicMT2 (Fig. 1). cicMT2 and N-TEV-C_cicMT2 show identical beha-
vior in the CdII titration experiment followed by UV spectroscopy, and
the binding capacity for five CdII ions is retained (Suppl. Mat.). The
position of the cleavage site before position Ser45 was on the one hand
chosen, because cleavage at the N-terminal site of a Ser residues has
been shown to be highly efficient [42]. On the other hand, cleavage in
roughly the center of the linker region adds half of its amino acids to
each of the two resulting peptides and hence should minimize the ef-
fects of the missing linker on the metal ion binding properties of the
terminal peptides. Initially it was planned to retain the GST fusion tag
at the N-terminus during the experiments to enable separation of the
otherwise similarly sized N- and C-termini by gel filtration after
Fig. 6. Deconvoluted ESI-MS spectra of N2 and C2 terminal peptides upon stepwise metallation with 0–5 CdII ions. The color of the numbers assigned to the peaks
corresponds to the color used for the labeling of the apo peptide forms.
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cleavage; however, initial experiments showed that GST significantly
alters the metal ion binding properties of the peptide compared to the
un-tagged protein. Therefore, the GST tag was removed via thrombin
cleavage prior to the metallation experiments. As before, cleavage
mixtures were analysed by ESI-MS. Results before addition of metal
ions reveal two peptide fragments: N1 with the additional six amino
acids of the TEV cleavage site (N1-TEV; Mr(obs) 5289.23 Da, Mr(calc)
5293.93 Da) and C1 (Mr(obs) 3475.33 Da, Mr(calc) 3478.85 Da)
(Fig. 7).
After addition of one CdII equivalent, Cd1 species of both peptides
are observed, again confirming the absence of any preference for one
domain over the other. In contrast to the proteinase K cleaved cicMT2
sample, no Cd2C1 species is observed while again a Cd2N1-TEV species
is seen. Addition of two metal ions reveals again a larger signal of the
Cd2N1-TEV species compared to the Cd1 form. No major changes
compared to previous results are obtained for the metallation with 3–5
CdII ions, except that no Cd3C1 species is observed in any of the spectra.
Also homo-dimer formation of the C-terminal peptide is again observed
after addition of four or five equivalents of CdII (Cd4(C1)2, Mr.(obs)
7397.64 Da, Mr.(calc) 7407.34 Da). Cluster formation between N1-TEV
and C1, however, is only observed when five CdII ions are added to this
construct. This delayed cluster formation is probably correlated to the
six additional amino acid of the TEV cleavage site in the center of the
linker region. Hence, the altered linker sequence seems to have an in-
fluence on the cluster formation ability of the protein.
3.2.4. 1:1 mixtures of N1 and C1
To evaluate the possibility that the six amino acids of the TEV
cleavage site (ENLYFQ) in N1-TEV influence its metal ion binding
abilities, N1 (residues 1–44) and C1 (45–78) were produced as separate
peptides (Fig. 1). The ESI-MS spectrum of the mixture acquired at acidic
conditions shows signals for both peptides, that is N1 (Mr(obs)
4346.1 Da, Mr(calc) 4354.93 Da) and C1 (Mr(obs) 3475.33 Da, Mr
(calc) 3478.85 Da) (Fig. 8). Upon metallation, two significant changes
compared to the N-TEV-C_cicMT2 construct can be seen. First, upon
addition of the first CdII ion no formation of the Cd2N1 species is
Fig. 7. Deconvoluted ESI-MS spectra of N-TEV-C_cicMT2 samples upon stepwise metallation with 0–5 CdII ions. The color of the numbers assigned to the peaks
corresponds to the color used for the labeling of the apo peptide forms.
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observed. Second, formation of a Cd3C1 species is again detected when
four or five CdII ions are added to the mixture. Cd1C1 has the highest
intensity of all species up to the addition of four CdII ions, while the
Cd2C1 species increases in intensity and becomes the major signal in the
spectra after addition of five CdII ions (Fig. 8). In the same spectrum,
and in agreement to the results with N-TEV-C_cicMT2, a Cd5N1C1
species can again be observed (Mr(obs) 8381.67 Da, Mr(calc)
8395.83 Da) next to Cd4- and Cd5(C1)2 homo-dimers. It is also intri-
guing that Cd4N1C1 cluster formation is already observed upon addi-
tion of three CdII equivalents, and upon addition of four metal ions
unprecedented formation of Cd2- and Cd3N1C1 species is observed next
to the Cd4N1C1 species, the origin of it not being clear.
3.2.5. Evaluation of cooperative behavior and influence of the linker region
on cluster formation
A summary of the results obtained with the proteolytically cleaved
full-length constructs cicMT2 and N-TEV-C_cicMT2, as well as with the
1:1 mixtures of the separate peptides N1/C1 and N2/C2, is presented in
Fig. 9 (tables with values are given in the SI). Upon stepwise addition of
CdII ions first formation of sub-metallated species is observed and hence
the metallation proceeds in absence of positive cooperativity. Domain
filling with positive cooperativity in place would result in a statistical
underrepresentation of intermediate metallated states, hence, for ex-
ample, after addition of one CdII equivalent (per domain or in total is
not really crucial) a Cd2N2 species would be already observed, but the
Cd1N2 form would be clearly diminished. This is obviously not the case.
After addition of one CdII ion exclusively Cd1N2 is, but no Cd2N2 is
detected (Fig. 9B). Addition of two CdII equivalents leads to the for-
mation of Cd2N2, but also considerable amounts of Cd1N2 are still
presence. Hence there is no positive cooperativity. On the other hand,
Cd2N2 is observed, but no Cd2C2. However, N2 and C2 must be con-
sidered as completely independent (and even physically separated)
protein domains, at least at lower CdII concentrations, and accordingly
the preferential filling of the N-terminal domain with metal ions is not
to be explained with cooperativity but with a higher binding affinity of
the N-terminal domain for CdII at certain metal-to-protein ratios (see
below). The same is true for the titration of the other three constructs
(Fig. 9A, C, D). Accordingly, presence of intermediate metallated states
Fig. 8. Deconvoluted ESI-MS spectra of N1 and C1 terminal peptides upon stepwise metallation with 0–5 CdII ions. The color of the numbers assigned to the peaks
corresponds to the color used for the labeling of the apo peptide forms.
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that become the most abundant species during the early and mid-stages
of the CdII titration experiment suggests that this metallation pathway
proceeds clearly in a noncooperative fashion [25]. From a thermo-
dynamic point of view, the affinities for coordination of the first CdII ion
to the N- or the C-terminal region are comparable, i.e. Kapp(Cd1N1/
N2) ≈ Kapp(Cd1C1/C2). Binding of two Cd
II to the N-terminus is ob-
served earlier than to the C-terminus and hence Kapp(Cd2N1/
N2) > Kapp(Cd2C1/C2). The reason for this might be just that the
number of Cys residues in the N-terminal Cys-rich region is higher (8
Cys versus 6). In addition, Cd3N1/N2 species are observed from addition
of three equiv. of CdII on, and hence at a titration point where mostly
Cd1C1/C2 still prevails over Cd2C1/C2. Accordingly it even seems that
Kapp(Cd3N1/N2) > Kapp(Cd2C1/C2).
While truncation of the linker region does not influence the binding
capacity of the peptides, there seems to be an influence on the forma-
tion of the Cd5NC cluster (Fig. 10). When the peptide mixtures are ti-
trated with CdII ions, it is obvious from the UV spectra that the addition
of more than two CdII equivalents causes the onset of some sort of
cluster formation (Fig. 3C). This can be sufficiently explained with the
formation of Cd3N species as well as increasing amounts of Cd2C species
that both require bridging thiolate groups. Both species are observed in
the respective ESI-MS spectra when three equiv. of CdII ions were added
to the mixtures (Figs. 5 and 8). Nevertheless, while in addition already a
small signal for a Cd5N2C2 species is observed at this titration point, the
Cd5N1C1 species can be only detected when five equiv. of Cd
II are
added to the N1/C1 mixture. Hence in the case of the separate terminal
peptides, the presence of parts of the linker region seems to, at first
glance, even hinder Cd5NC cluster formation. Comparing this with the
results obtained with the full-length proteins, ESI-MS spectra of the
digested cicMT2 protein show a Cd5 cluster involving the (partially
Fig. 9. Metallation of the N- and C-terminal Cys-rich regions as a function of CdII added to the solution. The relative percentage of a species is calculated for each
peptide fragment separately with 100% referring to the highest peak of a given species in all spectra of a given titration with 0–5 equiv. CdII. The left graph of each
part refers always to the N-, the right part to the C-terminal fragment. A) Proteinase K cleaved cicMT2, B) 1:1 mixture of N2/C2, C) TEV cleaved N-TEV-C_cicMT2, D)
1:1 mixture of N1/C1.
Fig. 10. Cluster formation of the type Cd5NC as a function of Cd
II ion added to
the solution.
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even more shortened) N2 /C2 peptides when four CdII ions were added,
while for the N-TEV-C_cicMT2 construct the Cd5 cluster only appears in
the spectra when five CdII ions were added. In addition to Cd5 cluster
formation, also Cd4 clusters are observed, in particular in the N1/C1
and N2/C2 mixtures upon addition of three CdII ion.
3.3. Structure compaction upon stepwise metallation of cicMT2
As MTs are to the largest extent devoid of secondary structural
elements, the folding heavily depends on metal ions [43–46]. Hence,
the folding process of cicMT2 was studied by observing the changes in
hydrodynamic radius (Rh) during the metallation process using DLS.
The data show a gradual decrease in Rh and hence a compaction of the
protein structure, from 3.02 ± 0.11 nm in apo-cicMT2 to
1.48 ± 0.04 nm in Cd5cicMT2 (Table 1). The observed radius for the
completely metallated protein (7.8 kDa for the protein part) is in good
agreement to literature values of proteins with similar molecular
weights: Aprotinin (6.8 kDa) has an Rh of 1.35 nm and cytochrome C
(12 kDa) of 1.77 nm [47]. The largest changes of approximately 0.5 nm
each are observed upon addition of the first and of the third CdII ion.
Considering the Rh of 3.0 nm for the apo-protein and making the rough
approximation that the N-terminal domain, the C-terminal domain and
the linker contribute 1/3 each to the total amino acid chain length,
contraction by 0.5 nm could be explained by folding of one domain (a
hairpin formed by a 1 nm stretch should have a length of roughly
0.5 nm), contraction by another 0.5 nm by folding of the second domain
(Fig. 11). Accordingly, upon addition of the first CdII ion, on average
one domain folds around the metal ion resulting in a Rh of 2.5 nm. Only
addition of a total of three CdII ions leads to the folding of the second
domain, i.e. Rh ~ 1.9 nm. The fourth and fifth equivalents cause further
compaction of the structure that is in accordance with Cd5 cluster for-
mation observed in ESI-MS now also involving the linker region,
leading finally to a Rh of 1.5 nm, which is half the radius seen for the
apo-protein. For comparison, the radius for Cd5N-TEV-C_cicMT2 is with
1.6 nm slightly larger, which might reflect the slightly longer linker
region in this construct.
3.4. Thermodynamic stability of CdII binding
5F-BAPTA is a fluorinated chelator that forms 1:1 complexes with
divalent metal ions and was incubated with Cd5cicMT2 as well as
Cd2C1/C2 and Cd3N1/N2 as competing ligand to determine the ap-
parent stability constants of the protein and peptides. The 19F NMR
spectra of the mixtures show in each case two main signals at −115 and
−123 ppm (Fig. S5), which correspond to Cd15F-BAPTA and free 5F-
BAPTA, respectively [48]. Peaks were integrated and the resulting
concentrations used to calculate the apparent CdII-binding constants for
each fully-metallated construct. Using the conditional stability constant
of Cd15F-BAPTA of 5.37 × 10
11 M−1 obtained with the program
Chelator [35] for 50 mM NaCl, pH 7.5, apparent stability constants were
calculated according to Hasler et al. [33] (Table 2, Data S3). It has to be
noted that in this way, only an apparent stability constant for one
average CdII binding site within a MT is obtained. Hence all binding
sites within a given MT are treated as equal and independent of each
other. The values for all constructs used in this study are in the order of
1011 M−1. The apparent binding constant to rabbit liver Cd7MT2 was
determined as a control and gave a log Kapp value of 14.44 ± 0.07 in
agreement with the literature (14.8) [33]. Hence the apparent stability
constants of the investigated constructs are all lower than the one ob-
tained for rabbit liver MT2, and are also lower than the ones of, for
example, human MT-3 (14.3) [33] or nematode MT-1 and MT-2 (13.1
and 15.0, respectively) [49]. However, with a log Kapp value of
11.94 ± 0.28 Cd5cicMT2 has a higher binding constant than the
bacterial MT from Pseudomonas fluorescens (log KCd 10.93) [32]. Lastly,
the wheat Ec-1 protein from the plant MT subfamily 4 that features 17
Cys residues as ligands, has a log KCd value of roughly 12–13 [50],
which is just slightly higher than the one of Cd5cicMT2. This is con-
sistent with the pH stability of both proteins. Also the pKa value of
Cd5cicMT2 is by 0.1 units higher than the one of Cd6Ec-1, equivalent
with a slightly reduced overall pH stability of Cd5cicMT2 compared to
Cd6Ec-1 [16,51]. Therefore, the results from the competition experi-
ment with 5F-BAPTA are well in-line with results from the literature.
4. Conclusions
The results presented here provide the first comprehensive in-
vestigation of the metallation pathway of a plant MT2 protein.
Investigating the folding of the full-length protein as well as of its se-
parate domains in presence of certain metal ion concentrations is es-
sential for understanding the role of MTs in the cellular environment.
The stepwise metallation with CdII reveals formation of sub-metallated
species, but no obvious positive cooperativity. This is advantageous in a
Table 1
Rh and polydispersity (Pd) values obtained by DLS for the stepwise metallation
of cicMT2 with CdII ions.
Rh (nm) Pd (%)
apo-cicMT2 3.02 ± 0.11 25.1 ± 2.8
Cd1cicMT2 2.52 ± 0.07 12.9 ± 2.3
Cd2cicMT2 2.33 ± 0.05 20.8 ± 1.4
Cd3cicMT2 1.85 ± 0.04 25.6 ± 2.8
Cd4cicMT2 1.66 ± 0.05 18.9 ± 2.3
Cd5cicMT2 1.48 ± 0.04 26.2 ± 1.6
Cd5N-TEV-C_cicMT2 1.60 ± 0.08 22.0 ± 1.7
Fig. 11. Schematic representation of the folding pathway upon metal ion
binding: light gray, N-terminal Cys-rich region; dark gray, C-terminal Cys-rich
region; black, linker region; gray balls, CdII ions. Note that after addition of 1
CdII ion, both coordination to the N- as well as to the C-terminal part is ob-
served.
Table 2
Apparent CdII binding constants (Kapp) of the separate fully-metallated terminal
peptides, the full-length cicMT2 protein, and rabbit liver MT2 as well as
equivalents of CdII removed by competition with 5F-BAPTA.
Kapp [M
−1] log (Kapp) Cd
II eq. removed
Cd3N2 5.30 × 10
11 11.71 ± 0.20 2.69 ± 0.03
Cd2C2 1.79 × 10
11 11.25 ± 0.05 1.91 ± 0.01
Cd3N1 5.80 × 10
11 11.76 ± 0.15 2.65 ± 0.01
Cd2C1 9.84 × 10
11 11.99 ± 0.03 1.71 ± 0.01
Cd5cicMT2 8.82 × 10
11 11.94 ± 0.28 4.43 ± 0.05
Cd7MT2 2.79 × 10
14 14.44 ± 0.07 1.05 ± 0.08
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sense as it prevents high abundance of apo-MT species, which would be
highly prone to proteolytic attack, while still offering ample free co-
ordination sites to ensure efficient binding of any free metal ions (es-
sential or toxic). In addition, non-coordinated Cys thiolate groups can
act as reactive oxygen species scavengers. The metallation pathway
presented here shows clearly that there is no preferential binding region
(N- or C-terminal) for the first CdII ion, while additional equivalents, i.e.
two and three, have a higher preference to coordinate to the N-terminal
region. This might be, at least in part, facilitated by the larger number
of Cys residues at the N-terminus (eight versus six). There is no obvious
influence of the linker region on the binding capacity of individual
domains. However, manipulation of the linker region, e.g. by introdu-
cing additional residues for TEV cleavage apparently affects early
cluster formation (addition of less than 5 CdII). In the experiments with
the N-TEV-C construct or with the 1:1 N1/C1 mixture, heterodimer Cd5-
cluster formation is only observed upon addition of 5 CdII ions. In
contrast, a Cd5 cluster is already detected in the experiments with full-
length cicMT2 or the 1:1 N2/C2 mixture after addition of 4 or 3
equivalents of CdII, respectively (Fig. 10). Hence while an intact linker
seems to promote cluster formation, hetero-dimerization of the separate
peptides is more efficient without additional residues from the linker
region or even from a TEV cleavage site.
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